Christian Plank

Company: Ethris

Job title: Managing Director, Chief Scientific & Technology Officer

Seminars:

INHALAMBDA: Modulating Host Immunity in The Airways With Interferon Lambda Encoding mRNA 9:30 am

Using Stabilised NanoParticle (SNaP) LNP platform to locally administer the drug to the lungs through inhalation or nasal spray Inducing an innate immune defence response in the mucosa at virus entry sites and inhibiting viral replication through extraordinarily stable lipidoid formulation of mRNDA Presenting preclinical results of antiviral efficacy of mRNA encoded IFN-lambda and Evaluating…Read more

day: Conference Day Two